Application of proprotein convertase subtilisin/kexin type 9 inhibitor, evolocumab, in patients with severe hypertriglyceridemia
oleh: Yanren Peng, Danxia Guo, Sijie Jiang, Hua Zheng, Lishao Guo
| Format: | Article |
|---|---|
| Diterbitkan: | Wolters Kluwer 2022-03-01 |
Deskripsi
No description available for this item.